Skip to main content
. 2016 Dec 9;7:578. doi: 10.3389/fimmu.2016.00578

Table 2.

The clinical characteristics of patients with Hashimoto’s thyroiditis, Graves’ disease, and healthy controls.

Variable HC HT GD Normal range
No. 30 36 30
Age (years) 37 ± 8 34 ± 9 30 ± 9
Gender (M/F) 4/26 4/32 5/25
Thyrotropin (mIU/L) 1.3 ± 0.2 14.2 ± 3.16 0.007 ± 0.01 0.35–4.94
FT4 (ng/dL) 1.4 ± 0.1 0.9 ± 0.2 46.02 ± 14.7 9.01–19.05
FT3 (pg/mL) 2.6 ± 0.5 3.7 ± 0.2 34.3 ± 6.9 2.63–5.70
Thyrotrophin receptor antibody (IU/L) 37.6 ± 9.5 0–1
TPOAb (IU/mL) 5.03 ± 0.7 343.27 ± 126.2 167.5 ± 23.2 0.11–5.23
TgAb (IU/mL) 2.54 ± 0.5 433.45 ± 102.7 192.28 ± 17.32 0.81–3.83

Data are expressed as mean ± SD. The “–” represents that the experiment was not performed, or the data are not applicable.

M, male; F, female; HT, Hashimoto’s thyroiditis; GD, Graves’ disease; HC, healthy controls.